Lessons on p53 from Mouse Models

作者: Dadi Jiang , Laura D. Attardi

DOI: 10.1007/978-1-4419-8231-5_2

关键词:

摘要: Mutations in the p53 gene are implicated development of at least half all human cancers, a wide variety types.1,2 This high incidence mutations suggests that there exists strong selection pressure for inactivation during tumorigenesis. The idea important tumor humans has also been supported by finding Li-Fraumeni syndrome, individuals inherit mutant allele and show predisposition to developing cancers.3 An unambiguous cause effect relationship, however, between mutation tumorigenesis clearly provided through generation analysis knockout mice.4–6 null mice subject 100% frequency, indicating presence is crucial preventing cancer development. In addition this initial observation, significant understanding role as suppressor come further mouse well other versions with altered genes. chapter, we will summarize various knock-in models how these have helped us understand function vivo.

参考文章(105)
Raymond E. Meyn, Brenda Hsu, Timothy J. McDonnell, Maria C. Marin, Larry A. Donehower, Adel K. El-Naggar, Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene. ,vol. 9, pp. 3107- 3112 ,(1994)
L. A. Donehower, J. L. A. Abrahamson, J. M. Lee, R. Kandel, A. Bernstein, Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene. ,vol. 9, pp. 3731- 3736 ,(1994)
Karlyne M. Reilly, Dagan A. Loisel, Roderick T. Bronson, Margaret E. McLaughlin, Tyler Jacks, Nf1 ; Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects Nature Genetics. ,vol. 26, pp. 109- 113 ,(2000) , 10.1038/79075
Charlotte Kuperwasser, Gregory D. Hurlbut, Frances S. Kittrell, Ellen S. Dickinson, Rudy Laucirica, Daniel Medina, Stephen P. Naber, D. Joseph Jerry, Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome. American Journal of Pathology. ,vol. 157, pp. 2151- 2159 ,(2000) , 10.1016/S0002-9440(10)64853-5
M S Greenblatt, W P Bennett, M Hollstein, C C Harris, Mutations in the p53 Tumor Suppressor Gene: Clues to Cancer Etiology and Molecular Pathogenesis Cancer Research. ,vol. 54, pp. 4855- 4878 ,(1994)
Cynthia Wetmore, Tom Curran, Derek E. Eberhart, Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Research. ,vol. 61, pp. 513- 516 ,(2001)
Steven E. Artandi, Sandy Chang, Shwu-Luan Lee, Scott Alson, Geoffrey J. Gottlieb, Lynda Chin, Ronald A. DePinho, Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice Nature. ,vol. 406, pp. 641- 645 ,(2000) , 10.1038/35020592
Jos Jonkers, Ralph Meuwissen, Hanneke van der Gulden, Hans Peterse, Martin van der Valk, Anton Berns, Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nature Genetics. ,vol. 29, pp. 418- 425 ,(2001) , 10.1038/NG747
CA Purdie, DJ Harrison, A Peter, L Dobbie, S White, SE Howie, DM Salter, CC Bird, AH Wyllie, ML Hooper, None, Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene Oncogene. ,vol. 9, pp. 603- 609 ,(1994)
M. DiRado, A. Bianchi, J. Caamano, A. J. P. Klein-Szanto, D. Trono, C. J. Conti, B. Ruggeri, T. Goodrow, Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Research. ,vol. 51, pp. 6615- 6621 ,(1991)